drugset / Trial / NCT07192341
Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to evaluate the effect of sacubitril/valsartan in patients with prosthetic heart valves with heart failure with reduced ejection fraction (HFrEF).
Timeline
- Start
- 2025-09-27
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sacubitril/Valsartan | Unknown | 100 mg | Oral |